Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 9;9:5800. doi: 10.1038/s41598-019-41701-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Differentially expressed gene screen. (A) Heatmap: A subset of genes whose expression was significantly associated with PTMC lymph node metastasis. (B) Venn diagram: Only two genes were overexpressed in both the lymph node metastasis group and the lethal outcome group (P < 0.05, fold change >2). MEDAG was one of these genes and exhibited a fold change >1.5 in the recurrence outcome group. The other instances of expression of this gene were so low as to be of no biological significance. (C) MEDAG mRNA Seq expression between the LNM-positive and LNM-negative groups (^#P = 0.029).